# Bart Neyns

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bart-neyns/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,850 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 68 |
| i10-index | 219 |
| Last Known Institution | Vrije Universiteit Brussel |
| OpenAlex ID | https://openalex.org/A5082449165 |
| ORCID iD | https://orcid.org/0000-0003-0658-5903 |
| Works | 520 |

## Researcher papers

- [Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-melanoma-who-progressed/)
- [Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer](https://scholariq.org/papers/durable-clinical-benefit-with-nivolumab-plus-ipilimumab-in-dna-mismatch-repair/)
- [Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma](https://scholariq.org/papers/stratified-phase-ii-trial-of-cetuximab-in-patients-with-recurrent-high-grade/)
- [ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee](https://scholariq.org/papers/esmo-consensus-conference-recommendations-on-the-management-of-metastatic/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

## Researcher university

- [Vrije Universiteit Brussel](https://scholariq.org/institutions/vrije-universiteit-brussel/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.